05:36 PM EDT, 03/27/2025 (MT Newswires) -- Annovis Bio ( ANVS ) said Thursday it has received a noncompliance notice from the New York Stock Exchange for market capitalization and stockholders' equity both below $50 million for 30 consecutive days.

It has notified the NYSE of its intention to submit a plan within 45 days detailing how it plans to regain listing compliance in the next 18 months, the company said in a statement.

The notice does not impact the company's operations or reporting obligations with the US Securities and Exchange Commission.